BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25373410)

  • 41. Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.
    Zhao J; Zhao Y; Xuan Y; Jiao W; Qiu T; Wang Z; Luo Y
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e125-9. PubMed ID: 26728670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters.
    Seder CW; Arndt AT; Jordano L; Basu S; Fhied CL; Sayidine S; Chmielewski GW; Gallo K; Liptay MJ; Borgia JA
    Ann Thorac Surg; 2017 Nov; 104(5):1637-1643. PubMed ID: 28964418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alternative splicing isoform of T cell factor 4K suppresses the proliferation and metastasis of non-small cell lung cancer cells.
    Fan YC; Min L; Chen H; Liu YL
    Genet Mol Res; 2015 Oct; 14(4):14009-18. PubMed ID: 26535715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
    Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
    Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer.
    Fu Y; Li Y; Wang X; Li F; Lu Y
    Cancer Biomark; 2020; 27(2):147-156. PubMed ID: 31771046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic impact of lymphovascular invasion compared with that of visceral pleural invasion in patients with pN0 non-small-cell lung cancer and a tumor diameter of 2 cm or smaller.
    Tao H; Hayashi T; Sano F; Takahagi A; Tanaka T; Matsuda E; Okabe K
    J Surg Res; 2013 Nov; 185(1):250-4. PubMed ID: 23830361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
    Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
    Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients.
    Zhu D; Chen H; Yang X; Chen W; Wang L; Xu J; Yu L
    Diagn Pathol; 2014 Nov; 9():198. PubMed ID: 25410592
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer.
    Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y
    Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
    Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
    J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
    Tan T; Xu XH; Lu XH; Wang XW
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
    Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
    Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancer.
    Song G; Guo G; Du T; Li X; Wang J; Yan Y; Zhao Y
    Exp Cell Res; 2020 Apr; 389(2):111884. PubMed ID: 32014444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer.
    Bria E; Milella M; Sperduti I; Alessandrini G; Visca P; Corzani F; Giannarelli D; Cerasoli V; Cuppone F; Cecere FL; Marchetti A; Sacco R; Mucilli F; Malatesta S; Guetti L; Vitale L; Ceribelli A; Rinaldi M; Terzoli E; Cognetti F; Facciolo F
    Lung Cancer; 2009 Dec; 66(3):365-71. PubMed ID: 19327866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients.
    Neri S; Yoshida J; Ishii G; Matsumura Y; Aokage K; Hishida T; Nagai K
    Ann Surg; 2014 Aug; 260(2):383-8. PubMed ID: 24646539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
    Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
    Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
    Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
    Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognosis of Different Types of Non-Small Cell Lung Cancer Progression: Current State and Perspectives.
    Schegoleva AA; Khozyainova AA; Fedorov AA; Gerashchenko TS; Rodionov EO; Topolnitsky EB; Shefer NA; Pankova OV; Durova AA; Zavyalova MV; Perelmuter VM; Denisov EV
    Cell Physiol Biochem; 2021 Mar; 55(S2):29-48. PubMed ID: 33687819
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
    Shi H; Ji Y; Li W; Zhong Y; Ming Z
    Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrin α11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence.
    Ando T; Kage H; Matsumoto Y; Zokumasu K; Yotsumoto T; Maemura K; Amano Y; Watanabe K; Nakajima J; Nagase T; Takai D
    Cancer Sci; 2020 Jan; 111(1):200-208. PubMed ID: 31778288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.